☆ 3.9 Editorial Material

Precision psychiatry

BRAZILIAN JOURNAL OF PSYCHIATRY (2022)

Related references

Note: Only part of the references are listed.

Review Psychiatry

Precision psychiatry in clinical practice

Raffaella Zanardi et al.

Summary: The treatment of depression is a major challenge for healthcare systems, but the integration of pharmacogenetic biomarkers into prescribing guidelines has led to a potential improvement in guiding prescriptions and may pave the way for the clinical application of polygenic predictors in the future. This advancement in precision psychiatry holds promise for personalized treatment options in depression.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2021)

Add to Collection

Article Clinical Neurology

Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder

Giuseppe Fanelli et al.

Summary: This study investigated the association between polygenic risk scores (PRS) and response to antidepressants in patients with major depressive disorder (MDD). Results showed that PRS did not predict treatment response, but SCZ-PRS was nominally associated with non-response. Patients with higher SCZ-PRS were more likely to be non-responders to antidepressants, indicating a potential genetic liability to schizophrenia affecting treatment response in MDD.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Add to Collection

Review Medicine, General & Internal